Journal Article

First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis

Yanli Zhuang; Cesar Calderon; Stanley J Marciniak; Esther Bouman-Thio; Philippe Szapary; Tong-Yuan Yang; Allen Schantz; Hugh M. Davis; Honghui Zhou; Zhenhua Xu

European Journal of Clinical Pharmacology · Vol. 72, Issue 11 · pp. 1303-1310 · 2016

View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

Journal	European Journal of Clinical Pharmacology
Publisher	Springer
Publication Date	2016-11-01
Publication Year	2016
Volume	72
Issue	11
Pages	1303-1310
Document Type	Journal Article
Print ISSN	0031-6970
eISSN	1432-1041
DOI	10.1007/s00228-016-2110-5

Access Information

NARA Access Coverage	1968-01-01~Current
Journal Homepage	https://www.springer.com/journal/228
Publisher Page	Open Publisher Page

Full-text access depends on NARA's subscribed coverage and institutional access.